Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 2
1965 5
1966 1
1968 2
1969 2
1970 6
1971 3
1972 6
1973 1
1974 5
1975 4
1976 6
1977 6
1978 10
1979 5
1980 4
1981 3
1982 12
1983 3
1984 5
1985 8
1986 10
1987 13
1988 8
1989 14
1990 17
1991 26
1992 40
1993 35
1994 38
1995 28
1996 46
1997 35
1998 44
1999 23
2000 17
2001 27
2002 25
2003 27
2004 22
2005 18
2006 25
2007 25
2008 21
2009 31
2010 25
2011 48
2012 49
2013 51
2014 51
2015 60
2016 52
2017 48
2018 51
2019 59
2020 50
2021 58
2022 30
Text availability
Article attribute
Article type
Publication date

Search Results

1,246 results
Results by year
Filters applied: . Clear all
Page 1
Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells.
Matsuyama S, Nao N, Shirato K, Kawase M, Saito S, Takayama I, Nagata N, Sekizuka T, Katoh H, Kato F, Sakata M, Tahara M, Kutsuna S, Ohmagari N, Kuroda M, Suzuki T, Kageyama T, Takeda M. Matsuyama S, et al. Among authors: nagata n. Proc Natl Acad Sci U S A. 2020 Mar 31;117(13):7001-7003. doi: 10.1073/pnas.2002589117. Epub 2020 Mar 12. Proc Natl Acad Sci U S A. 2020. PMID: 32165541 Free PMC article.
Efficacy and Safety of Early vs Elective Colonoscopy for Acute Lower Gastrointestinal Bleeding.
Niikura R, Nagata N, Yamada A, Honda T, Hasatani K, Ishii N, Shiratori Y, Doyama H, Nishida T, Sumiyoshi T, Fujita T, Kiyotoki S, Yada T, Yamamoto K, Shinozaki T, Takata M, Mikami T, Mabe K, Hara K, Fujishiro M, Koike K. Niikura R, et al. Among authors: nagata n. Gastroenterology. 2020 Jan;158(1):168-175.e6. doi: 10.1053/j.gastro.2019.09.010. Epub 2019 Sep 26. Gastroenterology. 2020. PMID: 31563627 Free article. Clinical Trial.
A SARS-CoV-2 antibody broadly neutralizes SARS-related coronaviruses and variants by coordinated recognition of a virus-vulnerable site.
Onodera T, Kita S, Adachi Y, Moriyama S, Sato A, Nomura T, Sakakibara S, Inoue T, Tadokoro T, Anraku Y, Yumoto K, Tian C, Fukuhara H, Sasaki M, Orba Y, Shiwa N, Iwata N, Nagata N, Suzuki T, Sasaki J, Sekizuka T, Tonouchi K, Sun L, Fukushi S, Satofuka H, Kazuki Y, Oshimura M, Kurosaki T, Kuroda M, Matsuura Y, Suzuki T, Sawa H, Hashiguchi T, Maenaka K, Takahashi Y. Onodera T, et al. Among authors: nagata n. Immunity. 2021 Oct 12;54(10):2385-2398.e10. doi: 10.1016/j.immuni.2021.08.025. Epub 2021 Aug 24. Immunity. 2021. PMID: 34508662 Free PMC article.
Phase Ib/II Study of Biweekly TAS-102 in Combination with Bevacizumab for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies (BiTS Study).
Satake H, Kato T, Oba K, Kotaka M, Kagawa Y, Yasui H, Nakamura M, Watanabe T, Matsumoto T, Kii T, Terazawa T, Makiyama A, Takano N, Yokota M, Okita Y, Matoba K, Hasegawa H, Tsuji A, Komatsu Y, Yoshino T, Yamazaki K, Mishima H, Oki E, Nagata N, Sakamoto J. Satake H, et al. Among authors: nagata n. Oncologist. 2020 Dec;25(12):e1855-e1863. doi: 10.1634/theoncologist.2020-0643. Epub 2020 Aug 3. Oncologist. 2020. PMID: 32666647 Free PMC article. Clinical Trial.
1,246 results